Annual EBIT:
$708.45M+$121.08M(+20.61%)Summary
- As of today, JAZZ annual earnings before interest & taxes is $708.45 million, with the most recent change of +$121.08 million (+20.61%) on December 31, 2024.
- During the last 3 years, JAZZ annual EBIT has risen by +$542.52 million (+326.96%).
- JAZZ annual EBIT is now at all-time high.
Performance
JAZZ EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$161.51M-$57.46M(-26.24%)Summary
- As of today, JAZZ quarterly earnings before interest & taxes is $161.51 million, with the most recent change of -$57.46 million (-26.24%) on September 30, 2025.
- Over the past year, JAZZ quarterly EBIT has dropped by -$98.70 million (-37.93%).
- JAZZ quarterly EBIT is now -37.93% below its all-time high of $260.21 million, reached on September 30, 2024.
Performance
JAZZ Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$515.36M-$98.70M(-16.07%)Summary
- As of today, JAZZ TTM earnings before interest & taxes is $515.36 million, with the most recent change of -$98.70 million (-16.07%) on September 30, 2025.
- Over the past year, JAZZ TTM EBIT has dropped by -$222.73 million (-30.18%).
- JAZZ TTM EBIT is now -33.83% below its all-time high of $778.87 million, reached on March 31, 2021.
Performance
JAZZ TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
JAZZ EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +20.6% | -37.9% | -30.2% |
| 3Y3 Years | +327.0% | +3.0% | -2.2% |
| 5Y5 Years | +34.5% | -21.7% | -16.5% |
JAZZ EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +938.0% | -37.9% | +389.0% | -30.2% | at low |
| 5Y | 5-Year | at high | +938.0% | -37.9% | +389.0% | -33.8% | +62.9% |
| All-Time | All-Time | at high | +603.9% | -37.9% | +245.2% | -33.8% | +396.5% |
JAZZ EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $161.51M(-26.2%) | $515.36M(-16.1%) |
| Jun 2025 | - | $218.97M(+491.8%) | $614.06M(+3.3%) |
| Mar 2025 | - | -$55.89M(-129.3%) | $594.53M(-18.2%) |
| Dec 2024 | $708.45M(+20.6%) | $190.77M(-26.7%) | $726.63M(-1.6%) |
| Sep 2024 | - | $260.21M(+30.5%) | $738.08M(+13.5%) |
| Jun 2024 | - | $199.44M(+161.7%) | $650.27M(+6.9%) |
| Mar 2024 | - | $76.21M(-62.3%) | $608.46M(-7.7%) |
| Dec 2023 | $587.37M(+794.8%) | $202.22M(+17.3%) | $659.31M(+15.9%) |
| Sep 2023 | - | $172.39M(+9.4%) | $568.70M(+2.8%) |
| Jun 2023 | - | $157.64M(+24.1%) | $553.16M(-6.4%) |
| Mar 2023 | - | $127.06M(+13.8%) | $591.03M(+7.2%) |
| Dec 2022 | -$84.54M(-151.0%) | $111.61M(-28.8%) | $551.53M(+4.6%) |
| Sep 2022 | - | $156.85M(-19.8%) | $527.09M(+16.6%) |
| Jun 2022 | - | $195.51M(+123.3%) | $452.01M(+42.9%) |
| Mar 2022 | - | $87.55M(+0.4%) | $316.41M(-19.1%) |
| Dec 2021 | $165.93M(-55.7%) | $87.18M(+6.6%) | $390.98M(-23.8%) |
| Sep 2021 | - | $81.77M(+36.5%) | $513.21M(-19.5%) |
| Jun 2021 | - | $59.91M(-63.0%) | $637.65M(-18.1%) |
| Mar 2021 | - | $162.12M(-22.6%) | $778.87M(+1.8%) |
| Dec 2020 | $374.80M(-28.8%) | $209.41M(+1.6%) | $765.46M(+24.0%) |
| Sep 2020 | - | $206.21M(+2.5%) | $617.29M(+3.6%) |
| Jun 2020 | - | $201.13M(+35.2%) | $595.96M(-0.9%) |
| Mar 2020 | - | $148.72M(+142.8%) | $601.32M(-6.4%) |
| Dec 2019 | $526.56M(-13.4%) | $61.24M(-66.9%) | $642.35M(-16.2%) |
| Sep 2019 | - | $184.88M(-10.5%) | $766.16M(-0.5%) |
| Jun 2019 | - | $206.48M(+8.8%) | $770.06M(+1.4%) |
| Mar 2019 | - | $189.74M(+2.5%) | $759.67M(+15.5%) |
| Dec 2018 | $607.96M(+17.2%) | $185.06M(-2.0%) | $657.73M(+5.8%) |
| Sep 2018 | - | $188.78M(-3.7%) | $621.88M(+4.6%) |
| Jun 2018 | - | $196.09M(+123.3%) | $594.56M(+5.1%) |
| Mar 2018 | - | $87.81M(-41.2%) | $565.51M(-7.9%) |
| Dec 2017 | $518.87M(-12.7%) | $149.21M(-7.6%) | $613.84M(-4.1%) |
| Sep 2017 | - | $161.45M(-3.3%) | $640.12M(+1.6%) |
| Jun 2017 | - | $167.04M(+22.7%) | $629.92M(-0.3%) |
| Mar 2017 | - | $136.14M(-22.4%) | $631.61M(+1.0%) |
| Dec 2016 | $594.39M(+20.6%) | $175.48M(+16.0%) | $625.38M(+6.2%) |
| Sep 2016 | - | $151.25M(-10.4%) | $589.14M(+3.5%) |
| Jun 2016 | - | $168.74M(+29.9%) | $569.42M(+2.8%) |
| Mar 2016 | - | $129.91M(-6.7%) | $553.98M(+2.3%) |
| Dec 2015 | $492.85M | $139.24M(+5.9%) | $541.74M(+0.4%) |
| Sep 2015 | - | $131.53M(-14.2%) | $539.60M(-0.3%) |
| Jun 2015 | - | $153.30M(+30.3%) | $541.41M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $117.67M(-14.2%) | $498.50M(+10.5%) |
| Dec 2014 | $204.27M(-39.0%) | $137.10M(+2.8%) | $451.18M(+8.6%) |
| Sep 2014 | - | $133.34M(+20.8%) | $415.27M(+7.1%) |
| Jun 2014 | - | $110.40M(+56.9%) | $387.60M(+8.0%) |
| Mar 2014 | - | $70.34M(-30.5%) | $358.89M(-1.6%) |
| Dec 2013 | $334.87M(+72.4%) | $101.19M(-4.2%) | $364.75M(+5.0%) |
| Sep 2013 | - | $105.67M(+29.4%) | $347.46M(+17.0%) |
| Jun 2013 | - | $81.69M(+7.2%) | $296.99M(+18.4%) |
| Mar 2013 | - | $76.20M(-9.2%) | $250.76M(+19.3%) |
| Dec 2012 | $194.22M(+53.4%) | $83.90M(+52.0%) | $210.14M(+24.3%) |
| Sep 2012 | - | $55.20M(+55.7%) | $169.11M(+10.1%) |
| Jun 2012 | - | $35.46M(-0.4%) | $153.61M(+1.1%) |
| Mar 2012 | - | $35.59M(-17.0%) | $152.01M(+9.3%) |
| Dec 2011 | $126.58M(+178.2%) | $42.86M(+8.0%) | $139.03M(+14.2%) |
| Sep 2011 | - | $39.70M(+17.3%) | $121.70M(+26.2%) |
| Jun 2011 | - | $33.86M(+49.8%) | $96.44M(+31.8%) |
| Mar 2011 | - | $22.60M(-11.5%) | $73.16M(+26.6%) |
| Dec 2010 | $45.50M(+185.6%) | $25.54M(+76.8%) | $57.79M(+32.3%) |
| Sep 2010 | - | $14.44M(+36.5%) | $43.66M(+32.6%) |
| Jun 2010 | - | $10.58M(+46.4%) | $32.93M(+8.4%) |
| Mar 2010 | - | $7.23M(-36.6%) | $30.38M(+90.7%) |
| Dec 2009 | $15.93M(+111.3%) | $11.41M(+207.6%) | $15.93M(+210.8%) |
| Sep 2009 | - | $3.71M(-53.8%) | -$14.38M(+68.6%) |
| Jun 2009 | - | $8.03M(+211.2%) | -$45.85M(+54.4%) |
| Mar 2009 | - | -$7.22M(+61.8%) | -$100.52M(+26.7%) |
| Dec 2008 | -$140.60M(-1.3%) | -$18.89M(+32.0%) | -$137.10M(+12.6%) |
| Sep 2008 | - | -$27.77M(+40.5%) | -$156.79M(-6.8%) |
| Jun 2008 | - | -$46.63M(-6.4%) | -$146.82M(-17.0%) |
| Mar 2008 | - | -$43.81M(-13.5%) | -$125.47M(-24.0%) |
| Dec 2007 | -$138.78M(-77.8%) | -$38.58M(-116.8%) | -$101.15M(+41.8%) |
| Sep 2007 | - | -$17.80M(+29.6%) | -$173.80M(-20.4%) |
| Jun 2007 | - | -$25.28M(-29.8%) | -$144.33M(-34.4%) |
| Mar 2007 | - | -$19.48M(+82.5%) | -$107.37M(-37.6%) |
| Dec 2006 | -$78.05M(-36.6%) | -$111.23M(-1052.9%) | -$78.05M(-94.9%) |
| Sep 2006 | - | $11.67M(0.0%) | -$40.04M(+13.6%) |
| Jun 2006 | - | $11.67M(+18.7%) | -$46.35M(+12.0%) |
| Mar 2006 | - | $9.84M(+113.4%) | -$52.67M(+7.8%) |
| Dec 2005 | -$57.14M(-130.4%) | -$73.23M(-1465.9%) | -$57.14M(-455.3%) |
| Sep 2005 | - | $5.36M(0.0%) | $16.08M(+50.0%) |
| Jun 2005 | - | $5.36M(0.0%) | $10.72M(+100.0%) |
| Mar 2005 | - | $5.36M | $5.36M |
| Dec 2004 | -$24.80M | - | - |
FAQ
- What is Jazz Pharmaceuticals plc annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual EBIT year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly EBIT year-on-year change?
- What is Jazz Pharmaceuticals plc TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc TTM EBIT year-on-year change?
What is Jazz Pharmaceuticals plc annual earnings before interest & taxes?
The current annual EBIT of JAZZ is $708.45M
What is the all-time high annual EBIT for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual earnings before interest & taxes is $708.45M
What is Jazz Pharmaceuticals plc annual EBIT year-on-year change?
Over the past year, JAZZ annual earnings before interest & taxes has changed by +$121.08M (+20.61%)
What is Jazz Pharmaceuticals plc quarterly earnings before interest & taxes?
The current quarterly EBIT of JAZZ is $161.51M
What is the all-time high quarterly EBIT for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly earnings before interest & taxes is $260.21M
What is Jazz Pharmaceuticals plc quarterly EBIT year-on-year change?
Over the past year, JAZZ quarterly earnings before interest & taxes has changed by -$98.70M (-37.93%)
What is Jazz Pharmaceuticals plc TTM earnings before interest & taxes?
The current TTM EBIT of JAZZ is $515.36M
What is the all-time high TTM EBIT for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high TTM earnings before interest & taxes is $778.87M
What is Jazz Pharmaceuticals plc TTM EBIT year-on-year change?
Over the past year, JAZZ TTM earnings before interest & taxes has changed by -$222.73M (-30.18%)